| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| H9PS37 | Cytochrome c oxidase subunit 3; | COX3; | NULL | 261 | human |
| H7C1K0 | Serrate RNA effector molecule homolog; Fragment; | SRRT; | NULL | 47 | human |
| H7C422 | 60S ribosomal protein L3; Fragment; | RPL3; | NULL | 305 | human |
| H9C3J9 | MHC class I antigen; Fragment; | HLA-A; | NULL | 72 | human |
| H7C2K7 | Sushi domain-containing protein 5; Fragment; | SUSD5; | NULL | 243 | human |
| H7C3I1 | Hsc70-interacting protein; Fragment; | ST13; | NULL | 146 | human |
| H7C5G4 | Replication factor C subunit 2; Fragment; | RFC2; | NULL | 101 | human |
| I6NWH3 | MHC class I antigen; Fragment; | HLA-A; | NULL | 181 | human |
| B3KNI3 | cDNA FLJ14651 fis, clone NT2RP2002193, highly similar to Protein inhibitor of activated STAT protein 3; | NULL | NP_006090.2; | 628 | human |
| I7API8 | MHC class I antigen; Fragment; | HLA-C; | NULL | 181 | human |
| H9RZ55 | ATP synthase protein 8; | ATP8; | NULL | 68 | human |
| B3KNJ9 | cDNA FLJ14720 fis, clone NT2RP3001495, highly similar to WW domain-containing oxidoreductase; EC 1.1.1.-; | NULL | NULL | 414 | human |
| B3KN67 | cDNA FLJ13779 fis, clone PLACE4000445, highly similar to Homo sapiens GTPase activating protein and VPS9 domains 1 (GAPVD1), mRNA; | NULL | NULL | 823 | human |
| H0YFP2 | WD repeat-containing protein 74; Fragment; | WDR74; | NULL | 38 | human |
| B3KR94 | cDNA FLJ33886 fis, clone CTONG2007399, highly similar to WD repeat protein 35; | NULL | NULL | 559 | human |
| I6QNF2 | MHC class I antigen; Fragment; | HLA-B; | NULL | 181 | human |
| I3UI80 | MHC class I antigen; Fragment; | HLA-A; | NULL | 181 | human |
| B3KTI5 | cDNA FLJ38324 fis, clone FCBBF3024663, weakly similar to Zyg-11 protein homolog; | NULL | NULL | 683 | human |
| I6VE27 | UDP-glucuronosyltransferase 1-1; EC 2.4.1.17; | BILIQTL1; | NULL | 533 | human |
| B3KMT2 | cDNA FLJ12511 fis, clone NT2RM2001727, highly similar to Homo sapiens ubiquitin protein ligase E3 component n-recognin 4 (UBR4), mRNA; | NULL | NULL | 817 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |